BioCentury
ARTICLE | Company News

Phenomenome, Polymedco deal

July 9, 2012 7:00 AM UTC

Polymedco received exclusive, U.S. commercialization rights to Phenomenome's gTA test. The companies submitted an application to FDA for the test, which Polymedco will market as Colon-Chek, as an aid...